Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Adaptyv has secured €34.35 million in Series A funding to scale its lab operations and expand research capabilities, led by Highland Europe with support from existing investors.

PRIVATEAug 28, 2026•about 3 hours ago

Amount Raised

€34.4 Million

Round Type

Series A

VaudBiotechnologyArtificial Intelligence

Investors

Y CombinatorBy FoundersAce VenturesHighland Europe

Description

Lausanne-based Adaptyv, a biotech startup, has raised €34.35 million in Series A funding. The funding will be used to enhance lab capacity, including opening a new facility in London and expanding its operations in Lausanne. The round was led by Highland Europe, with participation from Ace Ventures, ByFounders, and Y Combinator. Adaptyv specializes in automated protein design, leveraging AI to bridge the gap between digital design and physical validation.

Company Information

Company

Adaptyv Biosystems

Location

Vaud, Switzerland

About

Adaptyv Biosystems is a biotech start-up based in Épalinges that focuses on automating the experimental validation of AI-generated protein designs. Their cloud-based laboratory enables researchers to conduct real-world validation tests while streamlining the design-test-learn cycle. Adaptyv has successfully collaborated with over 30 pharma, biotech, and AI research partners, demonstrating significant improvements in protein success rates. The company aims to enhance automation and make experimental validation more scalable.

Don't miss Adaptyv Biosystems's next move

Get an email the moment Adaptyv Biosystems raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Adaptyv Biosystems's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Adaptyv Biosystems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.